School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Evotec SE EVO

Healthcare · Life Sciences Tools & Services

€1.37last close 2026-10-12 · delayed data

Trailing returns

1M-20.98%
3M-51.00%
6M-48.02%
1Y-64.67%
5Y-93.95%

Basis: Adjusted daily closes.

What it does

Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just – Evotec Biologics.

Open EVO in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies